J. Ichikawa

发表

Valproate and carbamazepine increase prefrontal dopamine release by 5-HT1A receptor activation.

H. Meltzer, J. Ichikawa, 1999, European journal of pharmacology.

Atypical, but Not Typical, Antipsychotic Drugs Increase Cortical Acetylcholine Release without an Effect in the Nucleus Accumbens or Striatum

Jin Dai, Herbert Y Meltzer, H. Meltzer, 2002, Neuropsychopharmacology.

The Effect of Streptozotocin-Induced Diabetes on Dopamine2, Serotonin1A and Serotonin2A Receptors in the Rat Brain

H. Meltzer, T. Sumiyoshi, J. Ichikawa, 1997, Neuropsychopharmacology.

Differential effects of repeated treatment with haloperidol and clozapine on dopamine release and metabolism in the striatum and the nucleus accumbens.

H. Meltzer, J. Ichikawa, 1991, The Journal of pharmacology and experimental therapeutics.

The effect of serotonin(1A) receptor agonism on antipsychotic drug-induced dopamine release in rat striatum and nucleus accumbens.

H. Meltzer, J. Ichikawa, 2000, Brain research.

Effect of antidepressants on striatal and accumbens extracellular dopamine levels.

H. Meltzer, J. Ichikawa, Herbert Y. Meltzer, 1995, European journal of pharmacology.

Effects of divalproex and atypical antipsychotic drugs on dopamine and acetylcholine efflux in rat hippocampus and prefrontal cortex

H. Meltzer, J. Ichikawa, Mei Huang, 2006, Brain Research.

N-Desmethylclozapine, a Major Metabolite of Clozapine, Increases Cortical Acetylcholine and Dopamine Release In Vivo Via Stimulation of M1 Muscarinic Receptors

H. Meltzer, J. Ichikawa, Mei Huang, 2005, Neuropsychopharmacology.

5-HT1A and 5-HT2A receptors minimally contribute to clozapine-induced acetylcholine release in rat medial prefrontal cortex

H. Meltzer, J. Ichikawa, J. Dai, 2002, Brain Research.

Serotonin receptors : their key role in drugs to treat schizophrenia

Yasuhiro Kaneda, Herbert Y Meltzer, Zhu Li, 2003, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

SR46349-B, a 5-HT2A/2C Receptor Antagonist, Potentiates Haloperidol-induced Dopamine Release in Rat Medial Prefrontal Cortex and Nucleus Accumbens

H. Meltzer, S. Bonaccorso, J. Ichikawa, 2002, Neuropsychopharmacology.

The effect of chronic atypical antipsychotic drugs and haloperidol on amphetamine-induced dopamine release in vivo

H. Meltzer, J. Ichikawa, 1992, Brain Research.

Relationship between dopaminergic and serotonergic neuronal activity in the frontal cortex and the action of typical and atypical antipsychotic drugs

H. Meltzer, J. Ichikawa, 1999, European Archives of Psychiatry and Clinical Neuroscience.

Clozapine increases both acetylcholine and dopamine release in rat ventral hippocampus: role of 5-HT1A receptor agonism

H. Meltzer, Young-Chul Chung, J. Ichikawa, 2004, Brain Research.

Effects of antipsychotic drugs on extracellular dopamine levels in rat medial prefrontal cortex and nucleus accumbens.

H. Meltzer, J. Ichikawa, T. Kuroki, 1999, The Journal of pharmacology and experimental therapeutics.

The effect of ipsapirone and S(−)-pindolol on dopamine release in rat striatum and nucleus accumbens

H. Meltzer, J. Ichikawa, 1999, Brain Research.

Aripiprazole, a novel antipsychotic drug, preferentially increases dopamine release in the prefrontal cortex and hippocampus in rat brain.

Jin Dai, Herbert Y Meltzer, Zhu Li, 2004, European journal of pharmacology.

5‐HT2A and D2 receptor blockade increases cortical DA release via 5‐HT1A receptor activation: a possible mechanism of atypical antipsychotic‐induced cortical dopamine release

H. Meltzer, S. Bonaccorso, H Y Meltzer, 2001, Journal of neurochemistry.

The effect of chronic clozapine and haloperidol on basal dopamine release and metabolism in rat striatum and nucleus accumbens studied by in vivo microdialysis.

H. Meltzer, J. Ichikawa, Herbert Y. Meltzer, 1990, European journal of pharmacology.

DOI, a 5-HT2A/2C receptor agonist, attenuates clozapine-induced cortical dopamine release

H. Meltzer, J. Ichikawa, J. Dai, 2001, Brain Research.

A comparison of the effects of loxapine with ziprasidone and thioridazine on the release of dopamine and acetylcholine in the prefrontal cortex and nucleus accumbens

H. Meltzer, J. Ichikawa, Zhu Li, 2003, Psychopharmacology.

Atypical antipsychotic drugs, quetiapine, iloperidone, and melperone, preferentially increase dopamine and acetylcholine release in rat medial prefrontal cortex: role of 5-HT1A receptor agonism

H. Meltzer, J. Ichikawa, J. Dai, 2002, Brain Research.

Acetylcholinesterase Inhibitors Are Neither Necessary nor Desirable for Microdialysis Studies of Brain Acetylcholine

H. Meltzer, J. Ichikawa, J. Dai, 2000 .

R(+)-8-OH-DPAT, a 5-HT1A receptor agonist, inhibits amphetamine-induced dopamine release in rat striatum and nucleus accumbens.

H. Meltzer, J. Ichikawa, T. Kuroki, 1995, European journal of pharmacology.

ACP-103, a 5-HT2A/2C inverse agonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens

H. Meltzer, A. Prus, J. Ichikawa, 2005, Psychopharmacology.

Cholinergic modulation of basal and amphetamine-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens

H. Meltzer, Young-Chul Chung, J. Ichikawa, 2002, Brain Research.

Increased S(−)-Apomorphine–Induced Vacuous Chewing and Attenuated Effect of Chronic Haloperidol Treatment in Streptozotocin-Induced Diabetic Rat

H. Meltzer, T. Sumiyoshi, J. Ichikawa, 1997, Pharmacology Biochemistry and Behavior.

Lithium differs from anticonvulsant mood stabilizers in prefrontal cortical and accumbal dopamine release: Role of 5-HT1A receptor agonism

H. Meltzer, J. Ichikawa, J. Dai, 2005, Brain Research.

5-HT2A receptor stimulation by DOI, a 5-HT2A/2C receptor agonist, potentiates amphetamine-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens

H. Meltzer, J. Ichikawa, T. Kuroki, 2003, Brain Research.

Effect of repeated administration of phencyclidine on spatial performance in an eight-arm radial maze with delay in rats and mice

H. Meltzer, J. Ichikawa, C. H. Kim, 2003, Pharmacology Biochemistry and Behavior.

Effect of antipsychotic drugs on extracellular serotonin levels in rat medial prefrontal cortex and nucleus accumbens.

H. Meltzer, J. Ichikawa, J. Dai, 1998, European journal of pharmacology.

5-HT2A receptor antagonism potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and inhibits that in the nucleus accumbens in a dose-dependent manner

H. Meltzer, J. Liégeois, J. Ichikawa, 2002, Brain Research.

DOI, a 5-HT2A/2C receptor agonist, potentiates amphetamine-induced dopamine release in rat striatum

H. Meltzer, J. Ichikawa, 1995, Brain Research.

5-HT 2A receptor stimulation by DOI, a 5-HT 2A/2C receptor agonist, potentiates amphetamine-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.

H. Meltzer, J. Ichikawa, T. Kuroki, 2003, Brain research.

The effect of serotonin1A receptor agonism on antipsychotic drug-induced dopamine release in rat striatum and nucleus accumbens

H. Meltzer, J. Ichikawa, 2000, Brain Research.

R(+)-8-OH-DPAT, a serotonin(1A) receptor agonist, potentiated S(-)-sulpiride-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens but not striatum.

H. Meltzer, J. Ichikawa, 1999, The Journal of pharmacology and experimental therapeutics.

Amperozide, a Novel Antipsychotic Drug, Inhibits the Ability of d‐Amphetamine to Increase Dopamine Release In Vivo in Rat Striatum and Nucleus Accumbens

H. Meltzer, J. Ichikawa, 1992, Journal of neurochemistry.

5-HT(1A) and 5-HT(2A) receptors minimally contribute to clozapine-induced acetylcholine release in rat medial prefrontal cortex.

H. Meltzer, J. Ichikawa, J. Dai, 2002, Brain research.

Differential effects of chronic imipramine and fluoxetine on basal and amphetamine-induced extracellular dopamine levels in rat nucleus accumbens.

H. Meltzer, J. Ichikawa, T. Kuroki, 1998, European journal of pharmacology.

Valproic acid potentiates both typical and atypical antipsychotic-induced prefrontal cortical dopamine release

H. Meltzer, Young-Chul Chung, J. Ichikawa, 2005, Brain Research.

R(+)-8-OH-DPAT, a 5-HT1A receptor agonist, inhibits amphetamine-induced serotonin and dopamine release in rat medial prefrontal cortex

H. Meltzer, J. Ichikawa, J. Dai, 1996, Brain Research.

R(+)-8-OH-DPAT, a selective 5-HT1A receptor agonist, attenuated amphetamine-induced dopamine synthesis in rat striatum, but not nucleus accumbens or medial prefrontal cortex

H. Meltzer, J. Ichikawa, J. Dai, 2000, Brain Research.

Apomorphine does not reverse reduced basal dopamine release in rat striatum and nucleus accumbens after chronic haloperidol treatment

H. Meltzer, J. Ichikawa, 1990, Brain Research.

5-HT(2A) receptor antagonism potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and inhibits that in the nucleus accumbens in a dose-dependent manner.

H. Meltzer, J. Liégeois, J. Ichikawa, 2002, Brain Research.

R(+)-8-OH-DPAT, a 5-HT1A receptor agonist, inhibits amphetamine-induced serotonin and dopamine release in rat medial prefrontal cortex

H. Meltzer, J. Ichikawa, T. Kuroki, 1996, Brain Research.

[Changes in behavior and central monoaminergic systems in the rat after repeated methamphetamine pretreatment: presynaptic regulatory mechanism].

J. Ichikawa, 1988, Yakubutsu, seishin, kodo = Japanese journal of psychopharmacology.